Reviv3 Procare Company announced that it has entered into a material definitive agreement for the private placement on a best efforts basis to accredited investors an aggregate of 1,947,175 shares of its common stock, par value $0.0001 per share at a purchase price of $0.23 per share for aggregate gross proceeds of $447,850.25 on February 23, 2023. The company relied on the exemption provided by Rule 506(b) of Regulation D promulgated under Section 4(a)(2) the Securities Act of 1933, as amended (the Act), in connection with the foregoing transactions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.675 USD | -3.03% | -10.44% | +0.87% |
May. 03 | AXIL Brands, Inc. Appoints Jeff Brown as Principal Financial Officer and Principal Accounting Officer | CI |
May. 03 | AXIL Brands, Inc. Announces CFO Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.87% | 51M | |
+12.28% | 388B | |
+12.61% | 136B | |
+16.62% | 76.27B | |
-12.57% | 65.56B | |
-15.65% | 44.23B | |
-10.36% | 36.96B | |
+6.37% | 35.04B | |
+7.80% | 18.02B | |
+12.30% | 15.57B |
- Stock Market
- Equities
- RVIV Stock
- News AXIL Brands, Inc.
- Reviv3 Procare Company announced that it expects to receive $0.44785 million in funding